Access cutting-edge generalized anxiety disorder treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Access generalized anxiety disorder specialists in Tucson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related generalized anxiety disorder treatment provided free
Generalized anxiety disorder (GAD) is usually treated with antidepressant therapy (ADT); however, sometimes ADTs alone are not enough to adequately treat GAD. The purpose of this study is to assess how safe and effective ABBV-932 is when added to the antidepressant therapies in adult participants with GAD who have had an inadequate response ADTs. ABBV-932 is an investigational drug being developed for the adjunctive treatment of GAD. Participants will be randomly assigned to receive ABBV-932 or
Sponsor: AbbVie
Check if you qualify for this generalized anxiety disorder clinical trial in Tucson, AZ
If you're searching for generalized anxiety disorder treatment options in Tucson, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced generalized anxiety disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.